These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32947183)

  • 21. Reduced striatal dopamine transporter density associated with working memory deficits in opioid-dependent male subjects: a SPECT study.
    Liang CS; Ho PS; Yen CH; Yeh YW; Kuo SC; Huang CC; Chen CY; Shih MC; Ma KH; Huang SY
    Addict Biol; 2016 Jan; 21(1):196-204. PubMed ID: 25439653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
    Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
    Brunswick DJ; Amsterdam JD; Mozley PD; Newberg A
    Am J Psychiatry; 2003 Oct; 160(10):1836-41. PubMed ID: 14514499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.
    Wiers CE; Lohoff FW; Lee J; Muench C; Freeman C; Zehra A; Marenco S; Lipska BK; Auluck PK; Feng N; Sun H; Goldman D; Swanson JM; Wang GJ; Volkow ND
    Eur J Neurosci; 2018 Aug; 48(3):1884-1895. PubMed ID: 30033547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
    Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
    J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental evaluation of absolute quantification in
    Zainudin NA; Zulkifli N; Hamid K; Hashim H; Mansor S
    J Appl Clin Med Phys; 2022 Aug; 23(8):e13723. PubMed ID: 35833589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
    Hwang WJ; Yao WJ; Wey SP; Ting G
    J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's disease.
    Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Batista IR; Paiva WS; de Andrade DC; Teixeira MJ; de Andrade LA; Barsottini OG; Shih MC; Bressan RA; Ferraz HB
    Med Sci Monit; 2014 Aug; 20():1413-8. PubMed ID: 25109468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
    Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
    Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.
    Hsiao MC; Lin KJ; Liu CY; Tzen KY; Yen TC
    Schizophr Res; 2003 Dec; 65(1):39-46. PubMed ID: 14623373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients.
    Schmitt GJ; Frodl T; Dresel S; la Fougère C; Bottlender R; Koutsouleris N; Hahn K; Möller HJ; Meisenzahl EM
    Eur Arch Psychiatry Clin Neurosci; 2006 Mar; 256(2):115-21. PubMed ID: 16284713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine transporter (DAT1) VNTR polymorphism and alcoholism in two culturally different populations of south India.
    Bhaskar LV; Thangaraj K; Wasnik S; Singh L; Raghavendra Rao V
    Am J Addict; 2012; 21(4):343-7. PubMed ID: 22691013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study.
    Yeh TL; Chen KC; Lin SH; Lee IH; Chen PS; Yao WJ; Lee SY; Yang YK; Lu RB; Liao MH; Chiu NT
    Psychopharmacology (Berl); 2012 Mar; 220(1):55-64. PubMed ID: 21881874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.
    Silva N; Szobot CM; Shih MC; Hoexter MQ; Anselmi CE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2014 Feb; 39(2):e129-34. PubMed ID: 23856832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis.
    Chen KC; Yang YK; Howes O; Lee IH; Landau S; Yeh TL; Chiu NT; Chen PS; Lu RB; David AS; Bramon E
    Schizophr Bull; 2013 Mar; 39(2):378-86. PubMed ID: 22156764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls.
    Amsterdam JD; Newberg AB
    Neuropsychobiology; 2007; 55(3-4):167-70. PubMed ID: 17657170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Availability of Striatal Dopamine Transporter in Healthy Individuals With and Without a Family History of ADHD.
    Tai YC; Chi MH; Chu CL; Chiu NT; Yao WJ; Chen PS; Yang YK
    J Atten Disord; 2019 May; 23(7):665-670. PubMed ID: 27401239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
    Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS
    J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine transporter density may be associated with the depressed affect in healthy subjects.
    Newberg A; Amsterdam J; Shults J
    Nucl Med Commun; 2007 Jan; 28(1):3-6. PubMed ID: 17159542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.